trending Market Intelligence /marketintelligence/en/news-insights/trending/mw0g_s5mcdiniidt1m-koq2 content esgSubNav
In This List

Former Boston Scientific CEO joins Corindus Vascular board

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Former Boston Scientific CEO joins Corindus Vascular board

Corindus Vascular Robotics Inc. appointed James Tobin to its board, effective immediately.

Tobin was the CEO of Boston Scientific Corp. from 1999 to 2009, a period that saw the company's revenues grow from nearly $2 billion to over $8 billion.

Tobin, who also serves on the boards of Oxford Immunotec Global PLC and Globus Medical Inc., is expected to help the Waltham, Mass.-based medical device maker in accelerating its business.